Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.

MLA

Ducassou, Stéphane, et al. “Clinical Presentation, Evolution, and Prognosis of Precursor B-Cell Lymphoblastic Lymphoma in Trials LMT96, EORTC 58881, and EORTC 58951.” British Journal of Haematology, vol. 152, no. 4, Feb. 2011, pp. 441–51. EBSCOhost, https://doi.org/10.1111/j.1365-2141.2010.08541.x.

APA

Ducassou, S., Ferlay, C., Bergeron, C., Girard, S., Laureys, G., Pacquement, H., Plantaz, D., Lutz, P., Vannier, J.-P., Uyttebroeck, A., & Bertrand, Y. (2011). Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951. British Journal of Haematology, 152(4), 441–451. https://doi.org/10.1111/j.1365-2141.2010.08541.x

Chicago

Ducassou, Stéphane, Céline Ferlay, Christophe Bergeron, Sandrine Girard, Geneviève Laureys, Hélène Pacquement, Dominique Plantaz, et al. 2011. “Clinical Presentation, Evolution, and Prognosis of Precursor B-Cell Lymphoblastic Lymphoma in Trials LMT96, EORTC 58881, and EORTC 58951.” British Journal of Haematology 152 (4): 441–51. doi:10.1111/j.1365-2141.2010.08541.x.